|
Samir Kaul is a founding general partner at Khosla Ventures and is focusing on clean technologies and life sciences investing. Since joining forces with Khosla, Samir has led the firm’s investments in Altra, Amyris, Cilion, Great Point Energy, Mascoma, Stion and a number of earlier science projects. Before joining Khosla Ventures, Samir was a partner at Flagship Ventures where he was a member of the Life Sciences team from 2002 through 2005. During that time he was also the founding-CEO of two Flagship start-ups, Codon Devices and Epitome Biosystems, and part of the founding team of a third Flagship start-up, Helicos Bio-Sciences. Prior to Flagship, Samir worked at the Institute for Genomic Research (TIGR). At TIGR, Samir led the Arabidopsis thaliana sequencing project, the first plant genome to be completely sequenced. | 